LncRNA MALAT1-deficiency restrains lipopolysaccharide (LPS)-induced pyroptotic cell death and inflammation in HK-2 cells by releasing microRNA-135b-5p

References

• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.
   PubMed Web of Science ®Google Scholar
• Shroff GR, Chang TI. Risk stratification and treatment of coronary disease in chronic kidney disease and End-Stage kidney disease. Semin Nephrol. 2018;38(6):582–599.
   PubMed Web of Science ®Google Scholar
• Siener R. Dietary treatment of metabolic acidosis in chronic kidney disease. Nutrients. 2018;10(4):512.
   Web of Science ®Google Scholar
• Fiorentino M, Grandaliano G, Gesualdo L, et al. Acute kidney injury to chronic kidney disease transition. Contrib Nephrol. 2018;193:45–54.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Saritas T, Eiwaz MB, et al. The acute kidney injury to chronic kidney disease transition in a mouse model of acute cardiorenal syndrome emphasizes the role of inflammation. Kidney Int. 2020;97(1):95–105.
   PubMed Web of Science ®Google Scholar
• Chung SD, Lai TY, Chien CT, Yu HJ. Activating nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney. PLoS One. 2012;7(10):e47299.
   PubMed Web of Science ®Google Scholar
• Xu G, Yue F, Huang H, et al. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis. Aging (Albany NY). 2016;8(5):977–985.
   PubMedGoogle Scholar
• Deng W, Chen K, Liu S, et al. Silencing circular ANRIL protects HK-2 cells from lipopolysaccharide-induced inflammatory injury through up-regulating microRNA-9. Artif Cells Nanomed Biotechnol. 2019;47(1):3478–3484.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bi X, Xiong J, et al. MicroRNA-34a promotes renal fibrosis by downregulation of klotho in tubular epithelial cells. Mol Ther. 2019;27(5):1051–1065.
   PubMed Web of Science ®Google Scholar
• Dastmalchi N, Safaralizadeh R, Nargesi MM. LncRNAs: potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem. 2020;27(30):5067–5077.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiang T, Zhou W, et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020;11(1):1000.
   PubMed Web of Science ®Google Scholar
• Tu C, Yang K, Wan L, et al. The crosstalk between lncRNAs and the hippo signalling pathway in cancer progression. Cell Prolif. 2020;53(9):e12887.
   PubMed Web of Science ®Google Scholar
• He Z, Yang D, Fan X, et al. The roles and mechanisms of lncRNAs in liver fibrosis. Int J Mol Sci. 2020;21(0 ):1482.
   Google Scholar
• Unfried JP, Fortes P. LncRNAs in HCV infection and HCV-related liver disease. Int J Mol Sci. 2020;21(6):2255.
   Web of Science ®Google Scholar
• Li N, Cui Y, Yin M, et al. Screening potential prognostic biomarkers of long non-coding RNAs for predicting the risk of chronic kidney disease. Braz J Med Biol Res. 2019;52(11):e8333.
   PubMed Web of Science ®Google Scholar
• Santer L, López B, Ravassa S, et al. Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease. Hypertension. 2019;73(4):820–828.
   PubMed Web of Science ®Google Scholar
• Tang L, Liu L, Li G, et al. Expression profiles of long noncoding RNAs in intranasal LPS-Mediated Alzheimer’s disease model in mice. BioMed Res Int. 2019;2019:1–14.
   Web of Science ®Google Scholar
• Li L, Zhang L, Zhang Y, et al. Inhibition of long non-coding RNA CTD-2574D22.4 alleviates LPS-induced apoptosis and inflammatory injury of chondrocytes. Curr Pharm Des. 2019;25(27):2969–2974.
   PubMed Web of Science ®Google Scholar
• Chen Y, Fu Y, Song YF, Li N. Increased expression of lncRNA UCA1 and HULC is required for pro-inflammatory response during LPS induced sepsis in endothelial cells. Front Physiol. 2019;10:608.
   PubMed Web of Science ®Google Scholar
• Mao Q, Liang XL, Zhang CL, et al. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10(1):393.
   PubMed Web of Science ®Google Scholar
• Song Y, Yang L, Guo R, et al. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochem Biophys Res Commun. 2019;509(2):359–366.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu X, Bai X, et al. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 2018;64(2):e12449.
   Web of Science ®Google Scholar
• Chen H, Wang X, Yan X, et al. RETRACTED: LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB. Int Immunopharmacol. 2018;55:69–76.
   PubMed Web of Science ®Google Scholar
• Huang M, Wang H, Hu X, et al. lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression. Oncoimmunology. 2019;8(1):e1518628.
   PubMed Web of Science ®Google Scholar
• Wang L, Qi Y, Wang Y, et al. LncRNA MALAT1 suppression protects endothelium against oxLDL-Induced inflammation via inhibiting expression of MiR-181b target gene TOX. Oxid Med Cell Longev. 2019;2019:8245810.
   PubMed Web of Science ®Google Scholar
• Han Y, Qiu H, Pei X, et al. Low-dose sinapic acid abates the pyroptosis of macrophages by downregulation of lncRNA-MALAT1 in rats with diabetic atherosclerosis. J Cardiovasc Pharmacol. 2018;71(2):104–112.
   PubMed Web of Science ®Google Scholar
• Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–335.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhuo H, Ye MY, et al. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Kaohsiung J Med Sci. 2020;36(9):682–691.
   PubMed Web of Science ®Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775.
   PubMed Web of Science ®Google Scholar
• Li DS, Ainiwaer JL, Sheyhiding I, et al. Identification of key long non-coding RNAs as competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 2016;20(11):2285–2295.
   PubMed Web of Science ®Google Scholar
• Liu P, Zhang B, Chen Z, et al. m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway. Aging (Albany NY). 2020;12(6):5280–5299.
   PubMedGoogle Scholar
• Cao DW, Liu MM, Duan R, et al. The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation. Acta Pharmacol Sin. 2020;41(1):22–33.
   PubMed Web of Science ®Google Scholar
• Ruan Z, Wang S, Yu W, et al. LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury. Int J Cardiol. 2019;288:122.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Run Q, Li CY, et al. LncRNA MALAT1 promotes STAT3-Mediated endothelial inflammation by counteracting the function of miR-590. Cytogenet Genome Res. 2020;160(10):565–578.
   PubMed Web of Science ®Google Scholar
• Dai L, Zhang G, Cheng Z, et al. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury. Connect Tissue Res. 2018;59(6):581–592.
   PubMed Web of Science ®Google Scholar
• Li J, Wang M, Song L, et al. LncRNA MALAT1 regulates inflammatory cytokine production in lipopolysaccharide-stimulated human gingival fibroblasts through sponging miR-20a and activating TLR4 pathway. J Periodontal Res. 2020;55(2):182–190.
   PubMed Web of Science ®Google Scholar
• Luo L, Wang Y, Hu P, et al. Long Non-Coding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) promotes hypertension by modulating the hsa-miR-124-3p/nuclear receptor subfamily 3, group C, member 2 (NR3C2) and hsa-miR-135a-5p/NR3C2 axis. Med Sci Monit. 2020;26:e920478.
   PubMed Web of Science ®Google Scholar
• Li A, Yu Y, Ding X, et al. MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway. Int J Cardiol. 2020;307:137–145.
   PubMed Web of Science ®Google Scholar
• Zeng R, Luo DX, Li HP, et al. MicroRNA-135b alleviates MPP+-mediated Parkinson's disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis . J Clin Neurosci. 2019;65:125–133.
   PubMed Web of Science ®Google Scholar
• Li P, Fan JB, Gao Y, et al. miR-135b-5p inhibits LPS-induced TNFα production via silencing AMPK phosphatase Ppm1e. Oncotarget. 2016;7(47):77978–77986.
   PubMedGoogle Scholar
• Garcia-Vives E, Solé C, Moliné T, et al. The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis. Int J Mol Sci. 2020;21(0 ):1372.
   Google Scholar
• Abdalrahim MS, Khalil AA, Alramly M, et al. Pre-existing chronic kidney disease and acute kidney injury among critically ill patients. Heart Lung. 2020;49(5):626–629.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Chinchilli VM, Coca S, et al. Post-Acute kidney injury proteinuria and subsequent kidney disease progression: the assessment, serial evaluation, and subsequent sequelae in acute kidney injury (ASSESS-AKI) study. JAMA Intern Med. 2020;180(3):402–410.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang L, Yang J, et al. Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway. BMC Complement Altern Med. 2019;19(1):107.
   PubMedGoogle Scholar
• Zhang K, Fan C, Cai D, et al. Contribution of TGF-Beta-Mediated NLRP3-HMGB1 activation to tubulointerstitial fibrosis in rat with angiotensin II-Induced chronic kidney disease. Front Cell Dev Biol. 2020;8:1.
   PubMed Web of Science ®Google Scholar
• Yang H, Lv H, Li H, et al. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways. Cell Commun Signal. 2019;17(1):62.
   PubMedGoogle Scholar
• Tian H, Wu M, Zhou P, et al. The long non-coding RNA MALAT1 is increased in renal ischemia-reperfusion injury and inhibits hypoxia-induced inflammation. Ren Fail. 2018;40(1):527–533.
   PubMed Web of Science ®Google Scholar